Pyxis Oncology, Inc.

Pyxis Oncology is a biotechnology company developing experimental cancer drugs. The company is testing several types of treatments designed to fight solid tumors, cancers that form in organs or tissues rather than blood. Their main approach uses antibody-drug conjugates, which are antibodies attached to cancer-fighting chemicals that target tumor cells. Pyxis has licensed technology from Pfizer and other partners and has several experimental drugs in early-stage human trials.